These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10204813)

  • 21. A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension.
    Huang QF; Sheng CS; Li Y; Dou Y; Zheng MS; Zhu ZM; Wang JG;
    J Clin Hypertens (Greenwich); 2019 May; 21(5):648-657. PubMed ID: 30973207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive effects of a new sustained-release formulation of nifedipine.
    Zachariah PK; Schwartz GL; Sheps SG; Schirger A; Carlson CA; Moore AG
    J Clin Pharmacol; 1990 Nov; 30(11):1012-9. PubMed ID: 2243148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
    Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of two modified release preparations of nifedipine-nifedipine retard 10 mg twice daily and nifedipine GITS 20 mg once daily--in the treatment of mild to moderate hypertension.
    Kirby BJ; Kitchin NR
    Int J Clin Pract; 1999; 53(5):339-43. PubMed ID: 10695096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension.
    Leonetti G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S31-4. PubMed ID: 1726003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2008 Aug; 21(8):948-54. PubMed ID: 18600215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ambulatory blood pressure-lowering effects of higher doses of different calcium antagonists in uncontrolled hypertension: the Calcium Antagonist Controlled-Release High-Dose Therapy in Uncontrolled Refractory Hypertensive Patients (CARILLON) Study.
    Mizuno H; Hoshide S; Tomitani N; Kario K
    Blood Press; 2017 Oct; 26(5):284-293. PubMed ID: 28524699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nifedipine tablets on ambulatory blood pressure in patients aged less than 60 and greater than 65 years with systemic hypertension.
    Kuwajima I; Suzuki Y; Shimosawa T; Otsuka K; Kawamura H; Kuramoto K
    Am J Cardiol; 1991 Nov; 68(13):1351-6. PubMed ID: 1951125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of antihypertensive drugs given once a day: the calcium antagonists revisited.
    Staessen JA; Celis H; Thijs L; Fagard R; Amery AK
    J Hypertens Suppl; 1994 Nov; 12(8):S107-15. PubMed ID: 7707149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine: cross-over study.
    Carroll J; Shamiss A; Zevin D; Levi J; Rosenthal T
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):974-7. PubMed ID: 8606536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bedtime dosing of barnidipine hydrochloride in non-dipper hypertensive patients with obstructive sleep apnoea not treated with continuous positive airway pressure.
    Crippa G; Zabzuni D; Cassi A; Bravi E
    Eur Rev Med Pharmacol Sci; 2016; 20(2):339-44. PubMed ID: 26875906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term safety and efficacy of high-dose controlled-release nifedipine (80 mg per day) in Japanese patients with essential hypertension.
    Shimamoto K; Kimoto M; Matsuda Y; Asano K; Kajikawa M
    Hypertens Res; 2015 Oct; 38(10):695-700. PubMed ID: 25876832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension.
    Spieker C
    Blood Press Suppl; 1998; 1():15-21. PubMed ID: 9660522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
    Graney WF
    Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.
    Galletti F; Barba G; Nardecchia A; Strazzullo P; Scagliusi P; Pirrelli A; Mancini M
    J Clin Pharmacol; 1994 Sep; 34(9):919-23. PubMed ID: 7983235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronobiological analysis by ambulatory blood pressure monitoring of the hyperbaric and hypobaric indexes for evaluation of the antihypertensive effect of long-acting nifedipine.
    Seki S; Taniguchi M; Ohsawa S; Koga A; Ito T; Kunoh M; Imamoto S; Miyazaki H; Takeda S; Iwano K; Satoh C; Kanae K; Mochizuki S
    Circ J; 2005 Oct; 69(10):1249-55. PubMed ID: 16195626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine.
    Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C
    J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.